Kris Persaud

发表

Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2.

M. Skobe, Yan Wu, K. Persaud, 2006, Cancer research.

Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity

J. Haidar, M. Kalos, S. Eastman, 2020, Cancer Immunology Research.

Kaposi's Sarcoma-associated Herpesvirus Activation of Vascular Endothelial Growth Factor Receptor 3 Alters Endothelial Function and Enhances Infection*

B. Chandran, J. Groopman, K. Persaud, 2005, Journal of Biological Chemistry.

Anti–Transforming Growth Factor β Receptor II Antibody Has Therapeutic Efficacy against Primary Tumor Growth and Metastasis through Multieffects on Cancer, Stroma, and Immune Cells

Zhen-ping Zhu, Yan Wu, D. Ludwig, 2010, Clinical Cancer Research.

Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision.

R. Dana, Yan Wu, K. Persaud, 2006, Proceedings of the National Academy of Sciences of the United States of America.

A recombinant, fully human, bispecific antibody neutralizes the biological activities mediated by both vascular endothelial growth factor receptors 2 and 3

Dan Lu, Zhen-ping Zhu, K. Persaud, 2005, Molecular Cancer Therapeutics.

A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth

K. Persaud, K. Paz, K. Credille, 2014, Cancer biology & therapy.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.

A bi-functional antibody-receptor domain fusion protein simultaneously targeting IGF-IR and VEGF for degradation

Zhen-ping Zhu, S. Eastman, Haifan Zhang, 2015, mAbs.

Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody.

M. Skobe, D. Hicklin, M. Swartz, 2005, Journal of the National Cancer Institute.

Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C

Zhen-ping Zhu, K. Persaud, J. Tille, 2004, Journal of Cell Science.

Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C

Zhen-ping Zhu, J. Tille, X. Jimenez, 2004 .

Identification of the Residues in the Extracellular Region of KDR Important for Interaction with Vascular Endothelial Growth Factor and Neutralizing Anti-KDR Antibodies*

P. Bohlen, Zhen-ping Zhu, P. Kussie, 2000, The Journal of Biological Chemistry.

Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth.

K. Alitalo, D. Hicklin, Takashi Takahashi, 2007, Cancer research.

The structural basis for the function of two anti-VEGF receptor 2 antibodies.

P. Kussie, Leyi Shen, Amtul Bari, 2011, Structure.

Removal of a C-terminal serine residue proximal to the inter-chain disulfide bond of a human IgG1 lambda light chain mediates enhanced antibody stability and antibody dependent cell-mediated cytotoxicity

Aiping Zhu, D. Ludwig, Amtul Bari, 2013, mAbs.

Development of a fully human anti-PDGFRbeta antibody that suppresses growth of human tumor xenografts and enhances antitumor activity of an anti-VEGFR2 antibody.

Zhen-ping Zhu, Haifan Zhang, D. Ludwig, 2009, Neoplasia.